"Clínica Central es un centro médico privado de complejidad media que sirve a varias localidades del Alto Valle y Valle Medio de Río Negro. Ofrece los siguientes servicios: • internación común y VIP • terapia intensiva • quirófanos • laboratorio de análisis clínicos acreditado por la Fundación Bioquímica Argentina • hemoterapia y banco de sangre • guardia con shockroom • consultorios ambulatorios para más de diez especialidades médicas • ART y medicina laboral • nutrición • centro de rehabilitación física integral propio con infraestructura y aparatología completa"

During the past decade, Clinica Central S.A. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Central S.A." #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Daniel Benjamin" with 1 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored, "Genova Inc." with 1 trials sponsored and "PharmaMar" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Central S.A." #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Central S.A." are "Covid19" (3 trials), "COVID-19" (2 trials), "COVID-19 Infection" (1 trials) and "Respiratory Syncytial Virus (RSV)" (1 trials). Many other conditions were trialed in "Clinica Central S.A." in a lesser frequency.

Most popular intervention types in "Clinica Central S.A." are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Remdesivir" (2 trials), "Abatacept" (1 trials), "Bamlanivimab" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Central S.A." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Central S.A.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clinica Central S.A., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Central S.A., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".